Skip to content

Clinical trials

Terminated Phase 2 Neuromuscular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuromuscular Diseases Phase: Phase 2 Status: Terminated Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20172
20191
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Flex Pharma, Inc.2
Fulcrum Therapeutics2
Centre d'Investigation Clinique et Technologique 8051
Penwest Pharmaceuticals Co.1
PepGen Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuromuscular Diseases7
Muscular Dystrophies3
Muscle Cramp2
Musculoskeletal Diseases2
Nervous System Diseases2
Neurodegenerative Diseases2
Spasm2
Amyotrophic Lateral Sclerosis1
Charcot-Marie-Tooth Disease1
Hereditary Sensory and Motor Neuropathy1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.